Gyre Therapeutics (GYRE) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Gyre Therapeutics (GYRE) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.59% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -76.72% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 85.51% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 12.13% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 90.10% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -48.36% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,170.12% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 99.48% |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | -117.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -117.12% |
| Mar 31, 2026 | -409.65% |
| Dec 31, 2025 | -83.36% |
| Sep 30, 2025 | 158.10% |
| Jun 30, 2025 | -2.32% |
| Mar 31, 2025 | -86.03% |
| Dec 31, 2024 | 100.63% |
| Sep 30, 2024 | -97.90% |
| Jun 30, 2024 | 112.30% |
| Mar 31, 2024 | 147.23% |
| Dec 31, 2023 | -1,866.61% |
| Sep 30, 2023 | 112.25% |
| Jun 30, 2023 | -134.73% |
| Mar 31, 2023 | 135.39% |
| Dec 31, 2022 | 181.13% |
| Sep 30, 2022 | -8,349.94% |
| Jun 30, 2022 | 636.23% |
| Mar 31, 2022 | 76.25% |
| Dec 31, 2021 | 72.56% |
| Sep 30, 2021 | 86.77% |